Hongfang Chen

Dr. Hongfang Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Stroke
Verified
Journal Article
Open access
HZHuan Zhou
Huan Zhou
WZWansi Zhong
Wansi Zhong
TZTingxia Zhang
Tingxia Zhang
CXChenghua Xu
Chenghua Xu
GZGenlong Zhong
Genlong Zhong
OGon behalf of the CASE-II Study Group
on behalf of the CASE-II Study Group
BACKGROUND: Current evidence provides limited support for the superiority of endovascular thrombectomy (EVT) in patients with M2 segment middle cerebral artery occlusion. We aim to investigate whether imaging features of M2 segment occlusion impact the effectiveness of EVT. METHODS: We conducted a retrospective cohort study from January 2017 to January 2022, drawing data from the CASE II registry (Computer-Based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation), which specifically documented patients with acute ischemic stroke presenting with M2 segment occlusion undergoing reperfusion therapy. Patients were stratified into the intravenous thrombolysis (IVT) group (IVT alone) and EVT group (IVT plus EVT or EVT alone). The primary outcome was a modified Rankin Scale score 0 to 2 at 90 days. Secondary outcomes included additional thresholds and distribution of modified Rankin Scale scores, 24-hour recanalization, early neurological deterioration, and relevant complications during hospitalization. Safety outcomes encompassed intracranial hemorrhagic events at 24 hours and mortality at 90 days. Binary logistic regression analyses with propensity score matching were used. Subgroup analyses were performed based on the anatomic site of occlusion, including right versus left, proximal versus distal, dominant/co-dominant versus nondominant, single versus double/triple branch(es), and anterior versus central/posterior branch. RESULTS: Among 734 patients (43.3% were females; median age, 73 years) with M2 segment occlusion, 342 (46.6%) were in the EVT group. Propensity score matching analysis revealed no statistical difference in the primary outcome (odds ratio, 0.860 [95% CI, 0.611–1.209]; P =0.385) between the EVT group and IVT group. However, EVT was associated with a higher incidence of subarachnoid hemorrhage (odds ratio, 6.655 [95% CI, 1.487–29.788]; P =0.004) and pneumonia (odds ratio, 2.015 [95% CI, 1.364–2.977]; P <0.001). Subgroup analyses indicated that patients in the IVT group achieved better outcomes when presenting with right, distal, or nondominant branch occlusion ( P all interaction <0.05). CONCLUSIONS: Our study showed similar efficiency of EVT versus IVT alone in acute M2 segment middle cerebral artery occlusion. This suggested that only specific patient subpopulations might have a potentially higher benefit of EVT over IVT alone. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT04487340.

8 September 2023 in Medicine
Verified
Journal Article
Open access
HCHongfang Chen
Hongfang Chen
JWJianwei Wang
Jianwei Wang
XPXiaoling Pan
Xiaoling Pan
MZMeixia Zhang
Meixia Zhang
Whether emergency medical service (EMS) improves the outcome of acute ischemic stroke (AIS) patients after intravenous thrombolysis (IVT) is still unknown among the severity of neurologic deficits. This study is to investigate the impact of EMS use on timely treatment and outcomes of AIS with IVT. This is a retrospective observational study. Clinical data after IVT from January 2017 to May 2020 were retrospectively analyzed, including onset-to-needle time (ONT), onset-to-door time (ODT). The patients were divided into EMS and non-EMS groups according to the method of admission. A good outcome was defined as a modified Rankin scale score of ≤2 at 3 months. The severity of neurological deficits was assessed using the national institutes of health stroke scale. A total of 2303 patients were analyzed (906 [(39.3%] female; mean age, 68 ± 13 year), and 1028 (44.6%) patients were transported by EMS and 1418 (67.9%) patients achieved good outcome. Among all patients, compared with non-EMS patients, EMS patients had shorter ONT (148 minutes vs 155 minutes, P = .002) and ODT (95 minutes vs 104 minutes, P < .001), but lower rate of good outcome (61.7% vs 73.0%, P < .001). The multivariate analysis showed that the use of EMS was negatively associated with ONT (ρ = −0.041, P = .048) and ODT (ρ = −0.051, P = .014). Among moderate to severe stroke patients, EMS was related with good outcome independently (OR: 3.101, 95%CI: 1.367–7.038, P = .007). In ischemic stroke, EMS can shorten the pre-hospital delay. Among moderate to severe stroke patients, EMS can further improve the outcome. But the study needs further validation.

26 August 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
CHChuan-Chen Hu
Chuan-Chen Hu
XPXiao-Ling Pan
Xiao-Ling Pan
MZMei-Xia Zhang
Mei-Xia Zhang
HCHongfang Chen
Hongfang Chen
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a treatable but frequently misdiagnosed autoimmune disease. Speech dysfunction, as one of the common manifestations of anti-NMDAR encephalitis, is usually reported as a symptom secondary to psychiatric symptoms or seizures rather than the initial symptom in a paroxysmal form. We report a case of anti-NMDAR encephalitis with paroxysmal speech disorder as a rare initial manifestation, and hope that it will contribute to the literature. A 39-year-old man with anti-NMDAR encephalitis initially presented with paroxysmal nonfluent aphasia and was misdiagnosed with a transient ischemic attack and cerebral infarction successively. The patient subsequently presented with seizures, but no abnormalities were found on brain magnetic resonance imaging or electroencephalogram. Cerebrospinal fluid (CSF) analysis revealed mild pleocytosis and increased protein levels. Anti-NMDAR antibodies in serum and CSF were detected for a conclusive diagnosis. After immunotherapy, the patient made a full recovery. This case suggests that paroxysmal speech disorder may be the presenting symptom of anti-NMDAR encephalitis in a young patient.

22 July 2025 in Cureus
Verified
Journal Article
Open access
PDF file
ZMZhang Meixia
Zhang Meixia
PXPan Xiaoling
Pan Xiaoling
HCHongfang Chen
Hongfang Chen
Isolated pulmonary arteriovenous fistula (PAVF) leading to paradoxical embolism and stroke is rare, particularly in cases involving large vessel occlusions. Here, we present the case of a 69-year-old female with occlusion of the M2 segment of the middle cerebral artery (MCA) and stenosis of the common carotid artery (CCA) caused by PAVF, which mimicked artery-to-artery embolism. CT angiography revealed occlusion of the left M2 segment of the MCA and stenosis of the CCA. After administration of recombinant tissue plasminogen activator, both the left MCA occlusion and CCA stenosis were completely recanalized. Transthoracic contrast echocardiography revealed a significant right-to-left shunt both at rest and during the Valsalva maneuver, while chest CT angiography indicated the presence of PAVF in the lower lobe of the right lung. The anticoagulant medication rivaroxaban (15 mg) was administered to prevent the recurrence of ischemic stroke. Pulmonary arterial angiography confirmed the diagnosis of PAVF, and PAVF embolization using coils was successfully performed. At the one-year follow-up, the patient had no stroke recurrence. PAVF is a potentially fatal but treatable disease. Even in patients with large vessel occlusions, it is essential to consider PAVF as a rare underlying cause. The mechanism of PAVF-related stroke might be mistaken for artery-to-artery embolism.

15 February 2024 in Research Square
Verified
Preprint
Open access
PDF file
MZMeixia Zhang
Meixia Zhang
XPXiaoling Pan
Xiaoling Pan
HCHongfang Chen
Hongfang Chen
Background: Pulmonary arteriovenous fistula (PAVF) induced paradoxical embolism leading to stroke is rare, especially large vessel occlusions. We presented a case of a 69-year-old female with middle cerebral artery (MCA) occlusion, initially responsive to thrombolysis. Case Presentation: The patient presented with sudden-onset aphasia, resolving partially but recurring. Imaging revealed left MCA occlusion and carotid stenosis. After recombinant tissue plasminogen activator use, left MCA completely recanalized and carotid stenosis dicovered. Trans‑cranial Doppler with positive bubble test discovered a significant right-to-left shunt and chest CT angiography suggested the formation of PAVFin the lower lobe of the right lung. Discussion: Although rare, PAVF is a potentially fatal but treatable cause of stroke. Even in large vessel occlusions patients, when considering embolic stroke of undetermined source, it is crucial to consider PAVF as a rare underlying cause.